至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Inactivation of XPF Sensitizes Cancer Cells to Gemcitabine.

J Nucleic Acids. 2019; 
GeorgeJoseph W,BesshoMika,BesshoTaday
Products/Services Used Details Operation
PCR Cloning and Subcloning … Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, 986805 Nebraska Medical Center, Omaha, NE 68198-6805, USA … Guide sequence for XPF (5′- gccggctcgacggattgcca-3′) was cloned into the transfer plasmid, pLentiCRISPR v2 (from …Guide sequence for XPF (5� -gccggctcgacggattgcca-3) wascloned into the transfer plasmid, pLentiCRISPR v2 (from GenScript). Get A Quote

摘要

Gemcitabine (2', 2'-difluorodeoxycytidine; dFdC) is a deoxycytidine analog and is used primarily against pancreatic cancer. The cytotoxicity of gemcitabine is due to the inhibition of DNA replication. However, a mechanism of removal of the incorporated dFdC is largely unknown. In this report, we discovered that nucleotide excision repair protein XPF-ERCC1 participates in the repair of gemcitabine-induced DNA damage and inactivation of XPF sensitizes cells to gemcitabine. Further analysis identified that XPF-ERCC1 functions together with apurinic/apyrimidinic endonuclease (APE) in the repair of gemcitabine-induced DNA damage. Our results demonstrate the importance of the evaluation of DNA repair activities... More

关键词